Publication | Open Access
Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and <i>In vivo</i> Growth of Human Oral Squamous Cell Carcinoma
161
Citations
38
References
2009
Year
Therapeutic approaches targeting IL-6R by tocilizumab may be effective for OSCC treatment by at least inhibiting angiogenesis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1